Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Head & Neck 2

Conditions

Head and Neck Neoplasms 15Squamous Cell Carcinoma of Head and Neck 8Radiation Injuries 5Xerostomia 3Drug-Related Side Effects and Adverse Reactions 3Salivary Gland Neoplasms 2Oropharyngeal Neoplasms 2Neoplasms, Unknown Primary 2Nasopharyngeal Neoplasms 2Mucositis 2Mouth Neoplasms 2Lung Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Kidney Neoplasms 1Esthesioneuroblastoma, Olfactory 1Deglutition Disorders 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 8Radiotherapy 7Radiation 4Injections 3Fibroblast Growth Factor 7 3Radiotherapy, Intensity-Modulated 2RRx-001 2Propolis 2Honey 2Amifostine 2pegfilgrastim 1oxycodone-acetaminophen 1kang-lai-te 1golotimod 1cyclohexaneacetic acid 1brilacidin 1acetaminophen, hydrocodone drug combination 1Xylitol 1Water 1Vaccinium myrtillus extract 1Traumeel S 1Tramadol 1Thioctic Acid 1Therapeutics 1Surgical Procedures, Operative 1Sucralfate 1Standard of Care 1Sodium Chloride 1Selenomethionine 1Pain Management 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mucositis × Amifostine × Head & Neck × Clear all
NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Vanderbilt-Ingram Cancer Center

Phase 2 Terminated
41 enrolled 12 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT00095927 2017-01-04

Randomized Amifostine For SCCHN

Dana-Farber Cancer Institute

Phase 2 Completed
58 enrolled
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Radiation Injuries, Xerostomia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡